These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Oxamniquine pharmacokinetics in healthy Kenyan African volunteers. Kokwaro GO; Taylor G East Afr Med J; 1991 May; 68(5):359-64. PubMed ID: 1935730 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cyclophosphamide in Kenyan African children with lymphoma. Juma FD; Koech DK; Kasili EG; Ogada T Br J Clin Pharmacol; 1984 Jul; 18(1):106-7. PubMed ID: 6743483 [No Abstract] [Full Text] [Related]
8. Effect of liver failure on the pharmacokinetics of cyclophosphamide. Juma FD Eur J Clin Pharmacol; 1984; 26(5):591-3. PubMed ID: 6468474 [TBL] [Abstract][Full Text] [Related]
9. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure. Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of cyclophosphamide in man after treatment with allopurinol. Witten J; Frederiksen PL; Mouridsen HT Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):392-4. PubMed ID: 7376891 [No Abstract] [Full Text] [Related]
12. Distribution and pharmacokinetics of cyclophosphamide in the rat. Talha MR; Rogers HJ; Trounce JR Br J Cancer; 1980 Jan; 41(1):140-3. PubMed ID: 7362775 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Juma FD; Rogers HJ; Trounce JR Br J Clin Pharmacol; 1979 Sep; 8(3):209-17. PubMed ID: 497087 [No Abstract] [Full Text] [Related]
14. The kinetics of salivary elimination of cyclophosphamide in man. Juma FD; Rogers HJ; Trounce JR Br J Clin Pharmacol; 1979 Nov; 8(5):455-8. PubMed ID: 508550 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of intravenous ketoprofen. Therapeutic value in renal colic]. Hurault de Ligny B; Debruyne D; Ryckelynck JP; Levaltier B; Albessard F; Moulin M Nephrologie; 1989; 10(1):23-6. PubMed ID: 2716941 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients. D'Incalci M; Facchinetti T; Bolis G; Mangioni C; Morasca L Eur J Drug Metab Pharmacokinet; 1979; 4(2):83-5. PubMed ID: 114397 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioavailability of cyclophosphamide from oral formulations. Wagner T; Fenneberg K Arzneimittelforschung; 1984; 34(3):313-6. PubMed ID: 6539613 [TBL] [Abstract][Full Text] [Related]
18. Studies on the pharmacokinetics of cyclophosphamide in sheep. Schaumlöffel E; Habermehl A; Brock N; Schneider B Arzneimittelforschung; 1973 Apr; 23(4):491-500. PubMed ID: 4740226 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of intravenously administered meptazinol during general anaesthesia in man. Gepts E; Sonck WA; Camu F; Vercruysse A Eur J Anaesthesiol; 1987 Jan; 4(1):35-43. PubMed ID: 3582376 [TBL] [Abstract][Full Text] [Related]
20. The influence of age on lignocaine pharmacokinetics in young puppies. Hastings CL; Brown TC; Eyres RL; Oppenheim RC Anaesth Intensive Care; 1986 May; 14(2):135-9. PubMed ID: 3740386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]